/APPB

APPB Stock - Applied Biosciences Corp.

Q: What is the analyst price target for APPB?

Analyst price target information is not currently available for APPB.

Q: What is APPB's market cap?

Market capitalization information is not currently available for APPB.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for APPB

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta732.83

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	$88,665	$723,351	$707,062	$197,554	$45,554
Gross Profit	$-317,884	$286,797	$185,288	$42,005	$39,163
Gross Margin	-358.5%	39.6%	26.2%	21.3%	86.0%
Operating Income	$-692,756	$-3,089,657	$-2,646,299	$-599,530	$-515,920
Net Income	$-767,220	$-4,673,557	$-2,629,327	$-2,376,101	$-517,656
Net Margin	-865.3%	-646.1%	-371.9%	-1202.8%	-1136.4%
EPS	$-0.04	$-0.34	$-0.22	$-0.16	$-0.04

Company Overview

Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.

Visit Website

Frequently Asked Questions about APPB

What is APPB's current stock price?

Applied Biosciences Corp. (APPB) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for APPB?

No analyst price targets are currently available for this stock.

What sector is Applied Biosciences Corp. in?

Applied Biosciences Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is APPB's market cap?

Applied Biosciences Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does APPB pay dividends?

No, Applied Biosciences Corp. does not currently pay a dividend to shareholders.